Close Menu

Betting on Biotech

Big pharma is taking big risks in its dealings with biotech, The Wall Street Journal's Jason Douglas says. Pushed by the market to get new products out, pharmaceutical companies are spending less on their own research and more on acquiring experimental compounds from biotech companies, even if they've barely begun to be tested.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers trace DNA on a clay pipe found at a former slave site to a population that lives in what is now Sierra Leone, the Washington Post reports.

Japan is to release rules governing some gene-edited food, according to NHK World.

Two researchers report on their genetic analysis of samples from a shawl thought to belong to a victim of Jack the Ripper, ScienceInsider reports.

In PLOS this week: computational strategy for improving gene set analysis testing, miRNAs linked to sleep apnea, and more.